Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
- PMID: 34292295
- PMCID: PMC8299355
- DOI: 10.1001/jamaoncol.2021.3127
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
Abstract
This case series examines the incidence, timing, and characteristics of mammographic axillary adenopathy following COVID-19 vaccination.
Conflict of interest statement
References
-
- US Centers for Disease Control . Local reactions, systemic reactions, adverse events, and serious adverse events: Moderna COVID-19 Vaccine. Accessed June 15, 2021. https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogeni...
-
- National Comprehensive Cancer Network . Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. Accessed June 15, 2021. https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccinat...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical